Julia R. Thibault

Julia Thibault is an associate in Dickinson Wright’s Denver office and a member of the firm’s Health Law Practice Group. She advises healthcare organizations on regulatory compliance, government investigations, risk management, employment, and corporate governance. She brings substantial experience leading legal teams and guiding organizations through high-stakes government investigations, operational remediation, financial distress, and organizational transformation.

Prior to joining Dickinson Wright, Julia served as General Counsel for a national medical technology company, where she advised executive leadership and the board on healthcare compliance, investigations, litigation, reimbursement, privacy, employment, and financial restructuring. Her experience provides a practical, business-focused perspective on the legal and operational challenges facing healthcare organizations.

• Served as General Counsel to a national medical technology company, overseeing corporate governance, legal strategy, and regulatory risk across national operations
• Secured a favorable Non-Prosecution Agreement with the U.S. Department of Justice and closure of investigations involving the SEC, HHS-OIG, DOD, FDA, Tricare/DHA, and other federal agencies
• Directed compliance remediation and an operational overhaul under a Non-Prosecution Agreement
• Advised a healthcare provider through a Chapter 11 restructuring and successful emergence under new private ownership within four months
• Represents healthcare providers in state and federal investigations, qui tam litigation, class actions, and other regulatory and commercial disputes
• Advises healthcare organizations on national reimbursement and payment matters involving federal and commercial payors, Medicare Advantage, Medicaid, workers’ compensation, and other payment sources
• Advises employers on executive agreements, non-competes, wage and hour, discrimination and harassment, workplace policies, and other employment matters

• Co-Author, “Overpayments Happen: Understanding CMS’s Updated 60-Day Rule,” Healthcare News, September 2026
• Author, “America’s Oldest Drug Cartel: Civil RICO Action In re Insulin Pricing Litigation and the Case for Overruling the Indirect Purchaser Rule,” American Journal of Law & Medicine, 2020